The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3HAMPA binding in rat brain synaptoneurosomes

Add time:09/08/2019    Source:sciencedirect.com

We previously demonstrated that potassium (KCl)-induced depolarization of synaptoneurosomes prepared from rat telencephalon increased [3Hamino-3-hydroxy-5-methylisoxazole-4-propionate ([3HAMPA) binding to the AMPA receptor. In the present study, we determined the effects of inhibitors of various calcium-dependent enzymes on this response to depolarization. Treatment of intact synaptoneurosomes with the phospholipase A2 (PLA2) inhibitor, bromophenacyl bromide (BPB), produced a marked and dose-dependent reduction in KCl-induced enhancement in [3HAMPA binding. BPB had no significant effect on [3HTPP accumulation in intact synaptoneurosomes, an index of membrane depolarization. In contrast to BPB, inhibitors of calcium-dependent kinases and proteases did not reduced the KCl-induced increase in [3HAMPA binding. The results strengthen the hypothesis that phospholipase-induced modifications of AMPA receptor properties may be an important component of synaptic plasticity.

We also recommend Trading Suppliers and Manufacturers of 3-BROMOPHENACYL BROMIDE (cas 18523-22-3). Pls Click Website Link as below: cas 18523-22-3 suppliers

Prev:Synthesis and cytotoxic activity of novel 1-((indol-3-yl)methyl)–1H-imidazolium salts
Next:Short crystallization paperCrystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 complexed with p-bromophenacyl bromide and α-tocopherol inhibitors at 1.9- and 1.45-Å resolution)